📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Romark

1.1 - Company Overview

Romark Logo

Romark

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of small-molecule therapies for infectious diseases and cancers, offering Alinia (nitazoxanide) for diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 1+; investigational NT-300 for COVID-19 and other viral respiratory illnesses; clinical trials and R&D in viral, cancer, pain, neurodegenerative and aging-related diseases.

Products and services

  • Alinia (nitazoxanide): Delivers an FDA-approved medication used to treat diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 1 year of age and older
  • Research and Development: Architects small-molecule programs discovering and developing new treatments for viral diseases, cancers, pain, neurodegenerative diseases, and aging-related diseases, advancing candidates across these therapeutic areas
  • NT-300 (nitazoxanide extended-release): Offers an investigational drug candidate being studied for prevention and treatment of COVID-19 and other viral respiratory illnesses

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Romark

Marinomed Biotech Logo

Marinomed Biotech

HQ: Austria Website
  • Description: Provider of biopharmaceutical therapies via patent-protected platforms, including MAVIREX-based products against respiratory viruses and the Marinosolv solubilization technology (available for partnerships via Solv4U). Portfolio includes Carragelose, Budesolv, Tacrosolv, and pipeline programs MAM-1004-2 (autoimmune gastritis) and MAM-1001-4 nasal spray.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Marinomed Biotech company profile →
Pacgen Life Science Logo

Pacgen Life Science

HQ: Canada Website
  • Description: Provider of life science technology focused on the commercialization of biomedical products and services, including prior development of novel therapeutic drug candidates; based in Vancouver, Canada.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pacgen Life Science company profile →
Elion Therapeutics Logo

Elion Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology solutions focused on treating life-threatening IFIs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elion Therapeutics company profile →
Evaxion Biotech Logo

Evaxion Biotech

HQ: Denmark Website
  • Description: Provider of AI-immunology™ platform-driven immunotherapies for cancer and infectious diseases, including EVX-01, a Phase 2 personalized cancer vaccine targeting patient-specific tumor antigens, and EVX-B1, a vaccine antigen against Staphylococcus Aureus, plus models PIONEER™, ObsERV™, and AI-DEEP™ for vaccine design and CPI response prediction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Evaxion Biotech company profile →
Tanomed Logo

Tanomed

HQ: Sweden Website
  • Description: Provider of medical product research and development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tanomed company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Romark

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Romark

2.2 - Growth funds investing in similar companies to Romark

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Romark

4.2 - Public trading comparable groups for Romark

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Romark

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Romark

What does Romark do?

Romark is a provider of small-molecule therapies for infectious diseases and cancers, offering Alinia (nitazoxanide) for diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 1+; investigational NT-300 for COVID-19 and other viral respiratory illnesses; clinical trials and R&D in viral, cancer, pain, neurodegenerative and aging-related diseases.

Who are Romark's competitors?

Romark's competitors and similar companies include Marinomed Biotech, Pacgen Life Science, Elion Therapeutics, Evaxion Biotech, and Tanomed.

Where is Romark headquartered?

Romark is headquartered in United States.

How many employees does Romark have?

Romark has 1,000 employees 🔒.

When was Romark founded?

Romark was founded in 2010 🔒.

What sector and industry vertical is Romark in?

Romark is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Romark

Who are the top strategic acquirers in Romark's sector and industry

Top strategic M&A buyers and acquirers in Romark's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Romark?

Top strategic M&A buyers groups and sectors for Romark include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Romark's sector and industry vertical

Which are the top PE firms investing in Romark's sector and industry vertical?

Top PE firms investing in Romark's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Romark's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Romark's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Romark's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Romark include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Romark's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Romark?

The key public trading comparables and valuation benchmarks for Romark include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Romark for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Romark with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Romark's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Romark with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Romark's' sector and industry vertical?

Access recent funding rounds and capital raises in Romark's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Romark